Intevac Announces First Quarter 2016 Financial Results
Mon, May 2 2016
“We are pleased to report financial results exceeding our expectations
for the first quarter of 2016, primarily due to the successful sign-off
and rapid customer acceptance achieved for our second VERTEX™ system
shipped to a leading display cover panel customer,” commented
“In the first quarter, our Photonics business continued to make
excellent progress developing the next-generation digital night vision
solutions for the military, including delivery of our high-resolution
ISIE 4000 goggle to
($ Millions, except per share |
Q1 2016 |
Q1 2015 |
|||||||||||||||||||
GAAP Results | Non-GAAP Results | GAAP Results | Non-GAAP Results | ||||||||||||||||||
Net Revenues |
$ |
13.7 |
$ | 13.7 | $ | 19.9 | $ | 19.9 | |||||||||||||
Operating Loss | $ | (6.3 | ) | $ | (6.3 | ) | $ | (2.9 | ) | $ | (2.8 | ) | |||||||||
Net Loss | $ | (6.3 | ) | $ | (6.3 | ) | $ | (2.9 | ) | $ | (2.8 | ) | |||||||||
Net Loss per Share | $ | (0.31 | ) | $ | (0.31 | ) | $ | (0.12 | ) | $ | (0.12 | ) | |||||||||
Intevac’s non-GAAP adjusted results exclude the impact of the following, where applicable: (1) restructuring charges; and (2) changes in fair value of contingent consideration liabilities associated with business combinations. A reconciliation of the GAAP and non-GAAP adjusted results is provided in the financial table included in this release. See also “Use of Non-GAAP Financial Measures” section.
First Quarter 2016 Summary
The net loss was
Revenues were
Thin-film Equipment gross margin was 9.0%, compared to 28.5% in the first quarter of 2015, and compared to 41.8% in the fourth quarter of 2015. The decline from the first quarter of 2015 and from the fourth quarter of 2015 was primarily due to lower revenue levels, including a lower level of higher margin upgrades, and lower factory absorption. Photonics gross margin was 41.5%, compared to 42.1% in the first quarter of 2015 and 39.6% in the fourth quarter of 2015. The decline from the first quarter of 2015 was due to higher factory overhead, due to the modified cost structure implemented in the second quarter of 2015, offset by favorable mix of product revenue versus lower margin contract research and development revenue. The improvement from the fourth quarter of 2015 was primarily due to favorable product mix. Consolidated gross margin was 28.2%, compared to 34.8% in the first quarter of 2015 and 40.7% in the fourth quarter of 2015.
R&
Order backlog totaled
The Company ended the quarter with
The Company did not repurchase any shares of common stock during the
first quarter. As of
Use of Non-GAAP Financial Measures
Management uses non-GAAP results to evaluate the Company’s operating and
financial performance in light of business objectives and for planning
purposes. These measures are not in accordance with GAAP and may differ
from non-GAAP methods of accounting and reporting used by other
companies.
Conference Call Information
The Company will discuss its financial results and outlook in a
conference call today at 1:30 p.m. PDT (4:30 p.m. EDT). To participate
in the teleconference, please call toll-free (877) 334-0811 prior to the
start time. For international callers, the dial-in number is
(408) 427-3734. You may also listen live via the
About
In our Thin-film Equipment business, we are a leader in the design and development of high-productivity, thin-film processing systems. Our production-proven platforms are designed for high-volume manufacturing of substrates with precise thin film properties, such as the hard drive media, display cover panel, and solar photovoltaic markets we serve currently.
In our Photonics business, we are a recognized leading developer of
advanced high-sensitivity digital sensors, cameras and systems that
primarily serve the defense industry. We are the provider of integrated
digital imaging systems for most
For more information call 408-986-9888, or visit the Company's website at www.intevac.com.
200 Lean® is a registered trademark and
Safe Harbor Statement
This press release includes statements that constitute “forward-looking
statements” within the meaning of the Private Securities Litigation
Reform Act of 1995 (the “Reform Act”).
|
|||||||
CONSOLIDATED STATEMENTS OF OPERATIONS |
|||||||
(Unaudited, in thousands, except per share amounts) |
|||||||
|
Three months ended | ||||||
|
|
||||||
Net revenues | |||||||
Thin-film Equipment |
|
|
|||||
Photonics |
8,084 | 9,257 | |||||
Total net revenues | 13,664 | 19,885 | |||||
Gross profit | 3,856 | 6,922 | |||||
Gross margin |
|||||||
Thin-film Equipment | 9.0% | 28.5% | |||||
Photonics | 41.5% | 42.1% | |||||
Consolidated | 28.2% | 34.8% | |||||
Operating expenses | |||||||
Research and development | 5,176 | 4,608 | |||||
Selling, general and administrative | 4,980 | 5,279 | |||||
Acquisition-related1 | 16 | (26) | |||||
Total operating expenses | 10,172 | 9,861 | |||||
Total operating loss | (6,316) | (2,939) | |||||
Operating income (loss) | |||||||
Thin-film Equipment | (5,445) | (3,297) | |||||
Photonics | 407 | 1,477 | |||||
Corporate | (1,278) | (1,119) | |||||
Total operating loss | (6,316) | (2,939) | |||||
Interest and other income | 37 | 79 | |||||
Loss before income taxes | (6,279) | (2,860) | |||||
Provision for income taxes | 26 | 33 | |||||
Net loss |
|
|
|||||
Loss per share | |||||||
Basic and Diluted |
|
|
|||||
Weighted average common shares outstanding | |||||||
Basic and Diluted |
20,551 | 23,229 | |||||
1Amounts for all periods presented include changes in fair value of contingent consideration obligations associated with the Solar Implant Technology (SIT) acquisition in 2010. |
|
|||||||||||
CONDENSED CONSOLIDATED BALANCE SHEETS |
|||||||||||
(In thousands, except par value) |
|||||||||||
|
|
||||||||||
(Unaudited) | (see Note) | ||||||||||
ASSETS | |||||||||||
Current assets | |||||||||||
Cash, cash equivalents and short-term investments | $ | 36,542 | $ | 36,954 | |||||||
Accounts receivable, net | 5,203 | 12,310 | |||||||||
Inventories | 20,368 | 18,760 | |||||||||
Prepaid expenses and other current assets | 1,599 | 1,712 | |||||||||
Total current assets | 63,712 | 69,736 | |||||||||
Long-term investments | 6,951 | 9,673 | |||||||||
Restricted cash | 1,780 | 1,780 | |||||||||
Property, plant and equipment, net | 12,208 | 11,921 | |||||||||
Intangible assets, net | 2,899 | 3,112 | |||||||||
Other long-term assets | 1,471 | 1,459 | |||||||||
Total assets | $ | 89,021 | $ | 97,681 | |||||||
LIABILITIES AND STOCKHOLDERS’ EQUITY | |||||||||||
Current liabilities | |||||||||||
Accounts payable | $ | 4,455 | $ | 5,950 | |||||||
Accrued payroll and related liabilities | 3,364 | 4,066 | |||||||||
Other accrued liabilities | 3,420 | 5,632 | |||||||||
Customer advances | 3,625 | 3,625 | |||||||||
Total current liabilities | 14,864 | 19,273 | |||||||||
Other long-term liabilities | 2,385 | 2,411 | |||||||||
Stockholders’ equity | |||||||||||
Common stock ( |
21 | 20 | |||||||||
Additional paid in capital | 168,482 | 166,514 | |||||||||
|
(28,489 | ) | (28,489 | ) | |||||||
Accumulated other comprehensive income | 523 | 412 | |||||||||
Accumulated deficit | (68,765 | ) | (62,460 | ) | |||||||
Total stockholders’ equity | 71,772 | 75,997 | |||||||||
Total liabilities and stockholders’ equity | $ | 89,021 | $ | 97,681 | |||||||
Note: Amounts as of |
|||||||||||
|
|||||
|
|||||
RECONCILIATION OF GAAP TO NON-GAAP RESULTS |
|||||
(Unaudited, in thousands, except per share amounts) |
|||||
Three months ended | |||||
|
|
||||
Non-GAAP Loss from Operations | |||||
Reported operating loss (GAAP basis) |
|
|
|||
Restructuring charges1 | — | 148 | |||
Change in fair value of contingent consideration obligations2 | 16 | (26) | |||
Non-GAAP Operating Loss |
|
|
|||
Non-GAAP Net Loss | |||||
Reported net loss (GAAP basis) |
|
|
|||
Restructuring charges1 | — | 148 | |||
Change in fair value of contingent consideration obligations2 | 16 | (26) | |||
Income tax effect of non-GAAP adjustments3 | — | — | |||
Non-GAAP Net Loss |
|
|
|||
Non-GAAP Loss Per Share | |||||
Reported loss per share (GAAP basis) |
|
|
|||
Restructuring charges1 | — | 0.01 | |||
Change in fair value of contingent consideration obligations2 | — | — | |||
Non-GAAP Loss Per Share |
|
|
|||
Weighted average number of shares outstanding | 20,551 | 23,229 | |||
1Results for all periods presented include severance and other employee-related costs related to various restructuring programs. |
|||||
2Results for all periods presented include changes in fair value of contingent consideration obligations associated with the Solar Implant Technology (SIT) acquisition in 2010. |
|||||
3The amount represents the estimated income tax effect of the non-GAAP adjustments. The Company calculated the tax effect of non-GAAP adjustments by applying an applicable estimated jurisdictional tax rate to each specific non-GAAP item.
|
View source version on businesswire.com: http://www.businesswire.com/news/home/20160502005531/en/
Chief Financial Officer
or
Investor Relations
Source: